Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
600
datasets available to search
ShareScore release 0.9.0
Dataset results
600 results for “Ophthalmitis”
Dataset for "Validation of a Prognostic Staging for Metastatic Uveal Melanoma: A Collaborative Study of the European Ophthalmic Oncology Group"
<p>Raw data corresponding to the paper entitled: "<strong>Validation of a Prognostic Staging for Metastatic Uveal Melanoma: A Collaborative Study of the European Ophthalmic Oncology Group</strong><strong>" </strong>published in <em>Am. J. Ophthalmol.</em> 2016 Aug;168:217-226 by Kivelä <em>et al.</em></p>
OLIVES Dataset: Ophthalmic Labels for Investigating Visual Eye Semantics
<p>Clinical diagnosis of the eye is performed over multifarious data modalities including scalar clinical labels, vectorized biomarkers, two-dimensional fundus images, and three-dimensional Optical Coherence Tomography (OCT) scans. While the clinical labels, fundus images and OCT scans are instrumental measurements, the vectorized biomarkers are interpreted attributes from the other measurements. Clinical practitioners use all these data modalities for diagnosing and treating eye diseases like Diabetic Retinopathy (DR) or Diabetic Macular Edema (DME). Enabling usage of machine learning algorithms within the ophthalmic medical domain requires research into the relationships and interactions between these relevant data modalities. Existing datasets are limited in that: (i) they view the problem as disease prediction without assessing biomarkers, and (ii) they do not consider the explicit relationship among all four data modalities over the treatment period. In this paper, we introduce the Ophthalmic Labels for Investigating Visual Eye Semantics (OLIVES) dataset that addresses the above limitations. This is the first OCT and fundus dataset that includes clinical labels, biomarker labels, and time-series patient treatment information from associated clinical trials. The dataset consists of $1268$ fundus eye images each with 49 OCT scans, and 16 biomarkers, along with 3 clinical labels and a disease diagnosis of DR or DME. In total, there are 96 eyes' data averaged over a period of at least two years with each eye treated for an average of 66 weeks and 7 injections. OLIVES dataset has advantages in other fields of machine learning research including self-supervised learning as it provides alternate augmentation schemes that are medically grounded.</p>
Dataset for study on persistence of onchocerciasis and associated dermatologic and ophthalmic pathologies after 27 years of ivermectin mass drug administration in the middle-belt of Ghana
<p>This is the dataset used for analysis in the study on persistence of onchocerciasis and associated dermatologic and ophthalmic pathologies after 27 years of ivermectin mass drug administration in the middle-belt of Ghana.</p>
Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis
ClinicalTrials.gov study NCT01363700. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Multi-Center, Randomized, Double Masked, Parallel-Group, Vehicle-Controlled, Clinical Study to Assess the Safety and Efficacy of Reproxalap Ophthalmic Solution in Subjects With Dry Eye Disease
ClinicalTrials.gov study NCT03404115. IPD Sharing: NO. Countries: 1. Publications: 1.
Efficacy and Safety Study of Netarsudil 0.02% Ophthalmic Solution Compared to Ripasudil Hydrochloride Hydrate 0.4% Ophthalmic Solution in Japanese Subjects With Primary Open Angle Glaucoma or Ocular H
ClinicalTrials.gov study NCT04620135. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of B + L Ophthalmic Viscosurgical Device (OVD) CVisc50
ClinicalTrials.gov study NCT04192630. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Physician's Evaluation of Cyclosporine Ophthalmic Emulsion 0.05%
ClinicalTrials.gov study NCT00827255. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy of Dexamethasone Ophthalmic Insert (Dextenza®) in the Management of Clinically Significant Dry Eye
ClinicalTrials.gov study NCT04498468. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study Evaluating the Efficacy of SAR 1118 (0.1%, 1.0%, 5.0%) Ophthalmic Solution in Subjects With Dry Eye Conducted in a Controlled Adverse Environment (CAE)
ClinicalTrials.gov study NCT00926185. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%
ClinicalTrials.gov study NCT03519386. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis in Pediatric Subjects
ClinicalTrials.gov study NCT05223478. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Neurotrophic Keratitis Subjects
ClinicalTrials.gov study NCT04909450. IPD Sharing: NO. Countries: 2. Publications: 1.
Efficacy of Besifloxacin Ophthalmic Suspension in the Treatment of Bacterial Conjunctivitis
ClinicalTrials.gov study NCT00972777. IPD Sharing: Not stated. Countries: 1. Publications: 3.
A Clinical Study to Assess the Safety and Efficacy of an Ophthalmic Solution (SkQ1) in the Treatment of Dry Eye Syndrome (DES)
ClinicalTrials.gov study NCT02121301. IPD Sharing: NO. Countries: 1. Publications: 1.
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension
ClinicalTrials.gov study NCT01157364. IPD Sharing: NO. Countries: 10. Publications: 2.
Double-masked Study of PG324 Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension
ClinicalTrials.gov study NCT02674854. IPD Sharing: NO. Countries: 1. Publications: 2.
Safety and Tolerability of the Ophthalmic Solution PRO-179 Compared With Travatan®
ClinicalTrials.gov study NCT03965052. IPD Sharing: NO. Countries: 1. Publications: 1.
Evaluation of the Efficacy in Decreasing Myopia Progression of the Proposed Ophthalmic Lens Prototypes
ClinicalTrials.gov study NCT05250206. IPD Sharing: NO. Countries: 1. Publications: 3.
Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-1)
ClinicalTrials.gov study NCT04246801. IPD Sharing: NO. Countries: 1. Publications: 11.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.